Carlotta Franchi1, Maura Marcucci2, Pier Mannuccio Mannucci3, Mauro Tettamanti4, Luca Pasina1, Ida Fortino5, Angela Bortolotti5, Luca Merlino5, Alessandro Nobili1. 1. Laboratory for Quality Assessment of Geriatric Therapies and Services, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy. 2. Geriatrics Unit, IRCCS Ca' Granda - Ospedale Maggiore Policlinico Foundation & Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. 3. A. Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS-Maggiore Hospital Foundation, Milan, Italy. 4. Laboratory of Geriatric Neuropsychiatry, IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy. 5. Regional health Ministry, Lombardy Region, Milan, Italy.
Abstract
PURPOSE: The purpose of this study is to explore the effect of incident chronic polypharmacy on 1-year hospitalization, institutionalization, and mortality among older people and to evaluate whether or not the effect differed according to index year (2001 or 2009), sex, and age. METHODS: Data were obtained from the administrative database of the Lombardy region (Northern Italy). We compared community-dwelling elderly people with an incident exposure to chronic polypharmacy (five or more drugs during 1 month for at least 6 months in 1 year) in either index year (2001 and 2009) with not exposed elderly people in the same years. Multivariable logistic (institutionalization) and Cox (hospitalization and death) were performed including year, sex, age classes, and number of drugs as covariates and their respective interaction terms by chronic polypharmacy. RESULTS: We analyzed 1,800,257 elderly subjects in 2001 and 1,567,575 in 2009, with a prevalence of chronic polypharmacy of 1.46% and 2.86%, respectively. Overall, 1-year hospitalization, institutionalization, and mortality rates were lower in 2009 than in 2001. Chronic polypharmacy was significantly associated with the outcomes in multivariable analyses: hazard or odds ratios 1.16 (95% confidence interval 1.14-1.17) for hospitalization, 1.21 (1.12-1.30) for institutionalization, and 1.11 (1.08-1.14) for death. There was no consistent effect modification by index year or sex, whereas chronic polypharmacy was no longer a risk factor for adverse outcomes among those older than 85 years (p < 0.0001 for interaction). CONCLUSIONS: Incident chronic polypharmacy remained an independent predictor of adverse outcomes among community-dwelling elderly people, despite a reduction over time of 1-year hospitalization, institutionalization, and mortality rates.
PURPOSE: The purpose of this study is to explore the effect of incident chronic polypharmacy on 1-year hospitalization, institutionalization, and mortality among older people and to evaluate whether or not the effect differed according to index year (2001 or 2009), sex, and age. METHODS: Data were obtained from the administrative database of the Lombardy region (Northern Italy). We compared community-dwelling elderly people with an incident exposure to chronic polypharmacy (five or more drugs during 1 month for at least 6 months in 1 year) in either index year (2001 and 2009) with not exposed elderly people in the same years. Multivariable logistic (institutionalization) and Cox (hospitalization and death) were performed including year, sex, age classes, and number of drugs as covariates and their respective interaction terms by chronic polypharmacy. RESULTS: We analyzed 1,800,257 elderly subjects in 2001 and 1,567,575 in 2009, with a prevalence of chronic polypharmacy of 1.46% and 2.86%, respectively. Overall, 1-year hospitalization, institutionalization, and mortality rates were lower in 2009 than in 2001. Chronic polypharmacy was significantly associated with the outcomes in multivariable analyses: hazard or odds ratios 1.16 (95% confidence interval 1.14-1.17) for hospitalization, 1.21 (1.12-1.30) for institutionalization, and 1.11 (1.08-1.14) for death. There was no consistent effect modification by index year or sex, whereas chronic polypharmacy was no longer a risk factor for adverse outcomes among those older than 85 years (p < 0.0001 for interaction). CONCLUSIONS: Incident chronic polypharmacy remained an independent predictor of adverse outcomes among community-dwelling elderly people, despite a reduction over time of 1-year hospitalization, institutionalization, and mortality rates.
Authors: Robin Brünn; Dorothea Lemke; Jale Basten; Petra Kellermann-Mühlhoff; Juliane Köberlein-Neu; Christiane Muth; Marjan van den Akker Journal: Pharmaceuticals (Basel) Date: 2022-06-17
Authors: Manon C Stam-Slob; Frank L J Visseren; J Wouter Jukema; Yolanda van der Graaf; Neil R Poulter; Ajay Gupta; Naveed Sattar; Peter W Macfarlane; Patricia M Kearney; Anton J M de Craen; Stella Trompet Journal: Clin Res Cardiol Date: 2016-08-23 Impact factor: 5.460
Authors: Lucas Morin; Kristina Johnell; Marie-Laure Laroche; Johan Fastbom; Jonas W Wastesson Journal: Clin Epidemiol Date: 2018-03-12 Impact factor: 4.790
Authors: Winn Cashion; William McClellan; Suzanne Judd; Abhinav Goyal; David Kleinbaum; Michael Goodman; Valerie Prince; Paul Muntner; George Howard Journal: Pharmacol Res Perspect Date: 2021-08